title: Induction of gicerin/CD146 in the rat carotid artery after balloon injury.
abstract: Gicerin is a cell adhesion molecule belonging to the immunoglobulin superfamily. It is reported that the human homologous molecule, CD146, is expressed in the endothelial cells. Here, we found that the expression of gicerin was increased in the rat carotid arteries after balloon injury. Immunohistochemical analysis demonstrated that the expression of gicerin protein was increased in the medial smooth muscle cells prior to the formation of neointima one week after the injury and was also increased in the luminal edge of the neointima after two weeks. We employed A10 cells, a cell line derived from rat aortic smooth muscle cell, and examined the effect of growth factors on the expression of gicerin, such as IGF-1, PDGF-BB, and bFGF. We found that IGF-1, but not PDGF-BB and bFGF, significantly increases the expression of gicerin protein in A10 cells. These suggest gicerin might be involved in the arteriosclerotic neointima formation in the artery.
authors.affiliation: Department of Pharmacology, Osaka University Medical School, 2-2 Yamada-oka, Suita, Osaka, 565-0871, Japan.
authors.forename: Shigeki
authors.initials: S
authors.lastname: Okumura
authors.forename: Keiko
authors.initials: K
authors.lastname: Kohama
authors.forename: Shokei
authors.initials: S
authors.lastname: Kim
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Iwao
authors.forename: Naomasa
authors.initials: N
authors.lastname: Miki
authors.forename: Eiichi
authors.initials: E
authors.lastname: Taira
mesh_terms: D000818:Animals; D015703:Antigens, CD; D001161:Arteriosclerosis / Q000209:etiology / Q000378:metabolism; D030161:Avian Proteins; D000077214:Becaplermin; D051929:CD146 Antigen; D020212:Carotid Artery Injuries / Q000378:metabolism* / Q000473:pathology; D002352:Carrier Proteins / Q000096:biosynthesis*; D015815:Cell Adhesion Molecules / Q000096:biosynthesis*; D002454:Cell Differentiation; D002460:Cell Line; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000494:pharmacology; D008562:Membrane Glycoproteins / Q000096:biosynthesis*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D019006:Neural Cell Adhesion Molecules; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology; D020574:Proto-Oncogene Proteins c-sis; D051381:Rats; D017207:Rats, Sprague-Dawley; D015854:Up-Regulation / Q000187:drug effects
chemical_list: D015703:Antigens, CD; D030161:Avian Proteins; D051929:CD146 Antigen; D002352:Carrier Proteins; D015815:Cell Adhesion Molecules; C497902:MCAM protein, human; D008562:Membrane Glycoproteins; D019006:Neural Cell Adhesion Molecules; D010982:Platelet-Derived Growth Factor; D020574:Proto-Oncogene Proteins c-sis; D016222:Fibroblast Growth Factor 2; D000077214:Becaplermin; D007334:Insulin-Like Growth Factor I